Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Nutlin, a TP53-MDM2 interaction inhibitor, is being investigated for soft-tissue sarcomas (STS).
• Mechanisms underlying secondary resistance to nutlin in STS remain largely unknown.

Purpose of the Study:

• To investigate the molecular mechanisms of secondary resistance to nutlin in soft-tissue sarcomas (STS).
• To identify genetic and molecular alterations associated with nutlin resistance.

Main Methods:

• Whole-transcriptome sequencing (RNA-seq) was performed on nutlin-sensitive and resistant STS cell lines.
• Analysis focused on identifying gene mutations, ploidy variations, and deregulation of apoptosis-related genes.

Main Results:

• Secondary resistance was linked to specific gene mutations (including TP53 in 2/3 lines) and ploidy variations.
• Deregulation of apoptosis-related genes and increased productive autophagy were observed in resistant cells.
• Inhibition of autophagy partially restored sensitivity to nutlin-induced cell death.

Conclusions:

• Secondary nutlin resistance in STS involves heterogeneous mechanisms driven by clonal evolution and multiple pathways.
• Targeting autophagy and exploring alternative dosing or combination therapies may overcome resistance.
• Further research is needed for successful clinical development of nutlin in STS.